Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.13 +0.10 (+2.48%)
At close: Sep 30, 2026 · 4:00 PM EDT

Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021)

Updated

Recursion Pharmaceuticals (RXRX) recorded Change in Receivables of -$114,000 in FY2021, compared with $5,000 in FY2020.

Analysis

Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021) Analysis & Trends

  • Per Business Quant data, RXRX's Change in Receivables was $5,000 in FY2020 (-81.5%) and $27,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Recursion Pharmaceuticals 2.21 Bn -397.37 Mn -3.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 -16,000.00
Jun 30, 2021 -13,000.00
Mar 31, 2021 -85,000.00
Dec 31, 2020 -30.04 Mn
Sep 30, 2020 30.19 Mn
Jun 30, 2020 -60,000.00
Mar 31, 2020 -82,000.00
API Access

Recursion Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RXRX&period=max&api_key=YOUR_API_KEY